Personalized lifestyle and medication program for severe mental illness
Treatments studied
Part of Mental health clinical trials.
This study tests a personalized program that combines lifestyle changes with medication to improve daily functioning in people with schizophrenia, bipolar disorder, or major depression. It aims to find the best combination for each person, including an injectable weight-management medication and a brain-stimulation option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a diagnosis of schizophrenia, bipolar disorder, or major depression.
- Your mental health symptoms have been stable for at least 2 weeks with your current medications.
- Your overall functioning is reduced, as measured by a standard health survey.
- You are willing to use effective birth control if you can become pregnant.
- You do not have serious medical conditions like pancreatitis, unmanaged diabetes, or certain thyroid disorders.
- If you want the weight-management medication, your body mass index (BMI) is above a certain level.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to improve heart health in people with schizophrenia or bipolar disorder who take antipsychotic medication or lithium and have a high body weight. The goal is to help reduce heart disease risk.
This study wants to see if a personalized approach with FDA-approved weight-loss medications can help people with bipolar disorder who are overweight or have obesity, while staying on their mood stabilizer treatment. It might be a good fit if you have bipolar disorder and struggle with your weight.
This study tests whether a weight-loss medication (a GLP-1 agonist) can change how the brain works and help with long-term weight control. It involves brain scans and a closely monitored treatment plan.
This study tests whether a weekly injection of semaglutide (a medication used for weight loss and diabetes) can help reduce symptoms of depression in people who have major depressive disorder and are overweight or obese.
This study tests whether semaglutide (a medicine used for diabetes and weight loss) can improve heart health and blood sugar in people with schizophrenia who also have metabolic syndrome. It may help lower the risk of heart problems in this group.
This trial studies how the body adapts to weight loss in teens with obesity. You will either get a behavioral lifestyle program alone or with a weight loss medication called semaglutide.
Hear when a new Severe Mental Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.